SCPH(Delisted)
Scpharmaceuticals (SCPH) Stock Statistics, Valuation & Financial Metrics
Total Valuation
Scpharmaceuticals market cap is -- and enterprise value is --.
Share Statistics
Scpharmaceuticals has 53.68M shares outstanding, with a free float of 36.37M.
Valuation Ratios
Scpharmaceuticals's PE ratio is --, PB ratio is --, and PS ratio is --, showing whether the stock looks expensive or cheap.
Solvency
Scpharmaceuticals debt-to-equity ratio is -- and debt-to-assets ratio is 1.27.
Liquidity
Scpharmaceuticals's current ratio is 3.85, quick ratio is 3.14, and cash ratio is 2, showing its short-term liquidity position.
Return on Capital
Scpharmaceuticals's ROE is --, ROA is -125.89%, and ROIC is -168.19%, showing its return on capital profile.
Profitability
Scpharmaceuticals gross margin is 68.46%, operating margin is -133.16%, and net margin is -183.55%.
Cost Structure
Scpharmaceuticals spends 30.87% of revenue on R&D and 170.76% on SG&A.
Operating Efficiency
Scpharmaceuticals's asset turnover is 0.69, inventory turnover is 1.05, and receivables turnover is 3.92, indicating its operating efficiency.
Income Statement
Scpharmaceuticals's revenue is 49.97M, gross profit is 34.21M, net income is -91.72M, and EBITDA is -66.50M.
Balance Sheet
Scpharmaceuticals's total debt is 51.20M, net debt is 10.39M, total equity is -21.32M, and cash is 40.81M.
Cash Flow Statement
Scpharmaceuticals's operating cash flow is -65.86M, free cash flow is -65.88M, and CapEx is --.
Dividends & Yields
Scpharmaceuticals dividend yield is --, with a payout ratio of -- and dividend per share of --.
Analyst Rating
Scpharmaceuticals's latest analyst rating is Unrate, with an analyst target price of --.
Company Info
A pharmaceutical company focused on therapies based on transformative pharmaceutical prducts
Per Share Metrics
Scpharmaceuticals's EPS is -1.81, book value per share is -0.4, and free cash flow per share is --.
